| Interventions to improve antibiotic prescribing practices for hospital inpatients P Davey, E Brown, E Charani, L Fenelon, IM Gould, A Holmes, ... Cochrane database of systematic reviews, 2013 | 2894 | 2013 |
| Understanding the mechanisms and drivers of antimicrobial resistance AH Holmes, LSP Moore, A Sundsfjord, M Steinbakk, S Regmi, A Karkey, ... The Lancet 387 (10014), 176-187, 2016 | 2752 | 2016 |
| Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing TM Rawson, LSP Moore, N Zhu, N Ranganathan, K Skolimowska, ... Clinical infectious diseases 71 (9), 2459-2468, 2020 | 1992 | 2020 |
| Expansion of the Gene Ontology knowledgebase and resources Gene Ontology Consortium Nucleic acids research 45 (D1), D331-D338, 2017 | 1818* | 2017 |
| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 936 | 2022 |
| Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum A Huttner, S Harbarth, J Carlet, S Cosgrove, H Goossens, A Holmes, ... Antimicrobial resistance and infection control 2, 1-13, 2013 | 608 | 2013 |
| Staphylococcus aureus Isolates Carrying Panton-Valentine Leucocidin Genes in England and Wales: Frequency, Characterization, and Association with Clinical … A Holmes, M Ganner, S McGuane, TL Pitt, BD Cookson, AM Kearns Journal of clinical microbiology 43 (5), 2384-2390, 2005 | 597 | 2005 |
| Hospital organisation, management, and structure for prevention of health-care-associated infection: a systematic review and expert consensus W Zingg, A Holmes, M Dettenkofer, T Goetting, F Secci, L Clack, ... The Lancet Infectious Diseases 15 (2), 212-224, 2015 | 593 | 2015 |
| Understanding the determinants of antimicrobial prescribing within hospitals: the role of “prescribing etiquette” E Charani, E Castro-Sánchez, N Sevdalis, Y Kyratsis, L Drumright, ... Clinical Infectious Diseases 57 (2), 188-196, 2013 | 488 | 2013 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 476 | 2021 |
| Machine learning for clinical decision support in infectious diseases: a narrative review of current applications N Peiffer-Smadja, TM Rawson, R Ahmad, A Buchard, P Georgiou, ... Clinical Microbiology and Infection 26 (5), 584-595, 2020 | 440 | 2020 |
| COVID-19 and the potential long-term impact on antimicrobial resistance TM Rawson, LSP Moore, E Castro-Sanchez, E Charani, F Davies, G Satta, ... Journal of antimicrobial chemotherapy 75 (7), 1681-1684, 2020 | 370 | 2020 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 365 | 2021 |
| Quantifying drivers of antibiotic resistance in humans: a systematic review A Chatterjee, M Modarai, NR Naylor, SE Boyd, R Atun, J Barlow, ... The Lancet Infectious Diseases 18 (12), e368-e378, 2018 | 360 | 2018 |
| Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London J Zhou, JA Otter, JR Price, C Cimpeanu, DM Garcia, J Kinross, ... Clinical infectious diseases: an official publication of the Infectious …, 2020 | 359* | 2020 |
| Health literacy and infectious diseases: why does it matter? E Castro-Sánchez, PWS Chang, R Vila-Candel, AA Escobedo, ... International Journal of Infectious Diseases 43, 103-110, 2016 | 308 | 2016 |
| Behavior change strategies to influence antimicrobial prescribing in acute care: a systematic review E Charani, R Edwards, N Sevdalis, B Alexandrou, E Sibley, D Mullett, ... Clinical Infectious Diseases 53 (7), 651-662, 2011 | 292 | 2011 |
| Antimicrobial use, drug-resistant infections and COVID-19 TM Rawson, D Ming, R Ahmad, LSP Moore, AH Holmes Nature Reviews Microbiology 18 (8), 409-410, 2020 | 283 | 2020 |
| Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? A Holmes, J Govan, R Goldstein Emerging infectious diseases 4 (2), 221, 1998 | 273 | 1998 |
| The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain L Sun, RZ Jiang, S Steinbach, A Holmes, C Campanelli, J Forstner, ... Nature medicine 1 (7), 661-666, 1995 | 258 | 1995 |
